희귀의약품 지정: 3-(3-(3,5-디메틸-1H-피라졸-4-일)프록시)-4-플루오로벤조산 ATTR 아밀로이드증 치료, 2018년 11월 19일 철회

Orphan designation: 3-(3-(3,5-Dimethyl-1H-pyrazol-4-yl)propoxy)-4-fluorobenzoic acid Treatment of ATTR amyloidosis, 19/11/2018 Withdrawn